12:00 AM
Aug 16, 2010
 |  BC Week In Review  |  Company News  |  Deals

Hawaii Bio, Merck deal

Merck acquired Hawaii Biotech's Dengue fever vaccine program for an undisclosed amount. The program has...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >